Benefits
Absorption compared with magnesium oxide
Magnesium citrate dissolved far better than magnesium oxide in lab tests, and after a single dose healthy volunteers excreted much more magnesium in urine, a sign of better absorption. In a 60-day randomized trial in 46 healthy adults taking 300 mg a day, citrate gave the highest blood magnesium, while oxide did not differ from placebo.
Osmotic laxative and bowel cleansing effect
Unabsorbed magnesium citrate pulls water into the bowel. In a randomized trial in 300 adults before colonoscopy, magnesium citrate taken the day before cleaned the bowel better than sodium phosphate, and a 51-person trial found a capsule regimen with bisacodyl worked as well as a 4-liter lavage. These are bowel-prep doses, larger than daily supplement amounts.
Blood magnesium levels
In a 60-day randomized, placebo-controlled trial in 46 healthy adults, 300 mg a day of elemental magnesium as citrate produced the highest blood magnesium after both the first dose and 60 days, and the highest saliva magnesium. Red blood cell magnesium did not differ between groups. The trial was in healthy people, not in people with low magnesium.
Headache frequency and severity
In a 3-month double-blind trial in 40 adults with migraine without aura, 600 mg a day of magnesium citrate reduced attack frequency and severity compared with placebo. Only 10 people received placebo, so the result needs confirmation. Frequent or severe headaches should be assessed by a doctor.
Urine oxalate and stone-risk markers
A small trial randomized 90 calcium stone formers with high urine oxalate to magnesium citrate (120 mg three times a day with meals), magnesium oxide or placebo for 8 weeks. Among the 76 analyzed, citrate lowered urine oxalate and calcium oxalate supersaturation versus placebo. Stone recurrence was not measured, and anyone who has had kidney stones should be under medical care.
Muscle soreness and recovery
Recovery data for the citrate form are thin. A review of 4 small studies of other forms (glycinate, oxide, lactate, unnamed) found less soreness or muscle damage after hard exercise, but the main soreness trial compared each group only with its own baseline. Citrate itself (300 mg a day) gave mixed bench press results in a small trial of 13 adults, and did not improve grip, leg strength or walking over 6 months in 49 adults with COPD.
Mechanism of action
Citric Acid Solubilization
Citric acid's three carboxyl groups complex with magnesium, maintaining solubility across gastric pH changes and improving absorption via standard divalent cation pathways.
Osmotic Bowel Effect
Unabsorbed magnesium and citrate ions in the bowel pull water into the lumen via osmosis, increasing stool volume and softening — laxative effect at higher doses.
NMDA receptor and calcium channel modulation
Magnesium blocks NMDA receptor channels at rest and modulates calcium channels in nerve and blood vessel cells. This is a proposed explanation for effects on headaches and blood vessels, not something the cited trials measured.
ATP Cofactor
Mg-ATP is the biologically active form of ATP; magnesium is required cofactor for >300 enzymes including all ATPases.
Clinical trials
Randomized, double-blind, placebo-controlled parallel trial of 300 mg/day elemental magnesium as amino-acid chelate, citrate or oxide for 60 days (Walker et al. 2003, Magnes Res)
46 healthy adults.
Citrate and amino-acid chelate raised 24-hour urinary magnesium more than oxide at 60 days. Citrate gave the highest blood magnesium after the first dose and after 60 days, and the highest saliva magnesium. Red blood cell magnesium did not differ, and oxide was no different from placebo.
Double-blind, randomized, placebo-controlled trial of 600 mg/day magnesium citrate for 3 months (Koseoglu et al. 2008, Magnes Res)
40 adults aged 20 to 55 with 2 to 5 migraine attacks a month (30 magnesium, 10 placebo).
Compared with placebo, attack frequency (p=0.005) and severity (p<0.001) fell more with magnesium citrate, and blood flow in some brain regions rose on scans. The placebo group was very small. Side effects were not reported in the abstract.
Randomized, double-blind, placebo-controlled trial of magnesium oxide or magnesium citrate (120 mg three times daily) for 8 weeks (Taheri et al. 2024, Magnes Res)
90 calcium stone formers with high urine oxalate enrolled; 76 analyzed.
Magnesium citrate lowered 24-hour urine oxalate (p=0.011) and calcium oxalate supersaturation (p=0.010) versus placebo; magnesium oxide moved in the same direction without reaching significance. Urine magnesium and citrate trended up without significant group differences. New stones were not measured.
Randomized, endoscopist-blinded comparison of magnesium citrate and sodium phosphate taken the day before colonoscopy (Berkelhammer et al. 2002, Gastrointest Endosc)
300 ambulatory adults having colonoscopy.
Magnesium citrate gave better bowel cleansing than sodium phosphate when both were taken the day before (p<0.001), and fewer rectal ulcers (1% versus 5.5%). Both were well tolerated. These are bowel-prep doses, not daily supplement amounts.